2019

Royer S, Di Patrizio P, Baumann C, Chapron A, Viennet S, Clerc-Urmès I, Schwan R, Bourion-Bédès S. Early satisfaction with care among outpatients with substance dependence. Encephale. 2019 Mar 14. pii: S0013-7006(19)30045-4. doi: 10.1016/j.encep.2019.02.006. [Epub ahead of print] French. PubMed PMID: 30879782. 

Schwitzer T, Schwan R, Angioi-Duprez K, Lalanne L, Giersch A, Laprevote V. Cannabis use and human retina: The path for the study of brain synaptic transmission dysfunctions in cannabis users. Neurosci Biobehav Rev. 2019 Feb 14. pii: S0149-7634(18)30331-2. doi: 10.1016/j.neubiorev.2018.12.001. [Epub ahead of print] Review. PubMed PMID: 30773228. 

Schwitzer T, Henrion ML, Sarre D, Albuisson E, Angioi-Duprez K, Giersch A, Lalanne L, Schwan R, Laprevote V. Spatial localization of retinal anomalies in regular cannabis users: The relevance of the multifocal electroretinogram. Schizophr Res. 2019 Jan 26. pii: S0920-9964(19)30013-1. doi:10.1016/j.schres.2019.01.013. [Epub ahead of print] PubMed PMID: 30696610. 

Pienkos E, Giersch A, Hansen M, Humpston C, McCarthy-Jones S, Mishara A, Nelson B, Park S, Raballo A, Sharma R, Thomas N, Rosen C (2019) Hallucinations beyond voices: A conceptual review of the phenomenology of altered perception in psychosis. Schizophrenia Bulletin, 45(Suppl 1), S67-S77. doi:10.1093/schbul/sby057. IF 7.757 [REVIEW 12]

Martin B,  Franck N, Giersch A (2019). A reflection upon methods to explore timing in patients with schizophrenia. Psych J 8(1):82-89. doi: 10.1002/pchj.268. [REVIEW 13]

Lucas A, Thirion A, Schwan R, Krieg J, Angioi-Duprez K, Laprevote V, Schwitzer T. Association between increased retinal background noise and co-occurrent regular cannabis and alcohol use. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:335-340. doi: 10.1016/j.pnpbp.2018.10.002. Epub 2018 Oct 5. PubMed PMID: 30292729.

Auriacombe M, Roux P, Briand Madrid L, Kirchherr S, Kervran C, Chauvin C, Gutowski M, Denis C, Carrieri MP, Lalanne L, Jauffret-Roustide M; and the Cosinus study group. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol. BMJ Open. 2019 Feb 21;9(2):e023683. doi: 10.1136/bmjopen-2018-023683.

Massotte D, Lalanne-Tongio L, Befort K. Addiction: A neurobiological and cognitive brain disorder. Neurosci Biobehav Rev. 2019 Nov;106:1-2. doi: 10.1016/j.neubiorev.2019.07.012. Epub 2019 Jul 29.

Dubreucq J, Ycart B, Gabayet F, Perier CC, Hamon A, Llorca PM, Boyer L, Godin O, Bulzacka E, Andrianarisoa M, Aouizerate B, Berna F, Brunel L, Capdevielle D, Chereau I, D'Amato T, Dubertret C, Faget C, Mallet J, Misdrahi D, Passerieux C, Rey R, Richieri R, Schandrin A, Schürhoff F, Urbach M, Vidailhet P, Giraud-Baro E, Fond G; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Towards an improved access to psychiatric rehabilitation: availability and effectiveness at 1-year follow-up of psychoeducation, cognitive remediation therapy, cognitive behaviour therapy and social skills training in the FondaMental Advanced Centers of Expertise-Schizophrenia (FACE-SZ) national cohort. Eur Arch Psychiatry Clin Neurosci. 2019 Apr 8. doi:10.1007/s00406-019-01001-4. PMID: 30963264. 

Berna F, Göritz AS, Mengin A, Evrard R, Kopferschmitt J, Moritz S. Alternative or complementary attitudes toward alternative and complementary medicines. BMC Complement Altern Med. 2019 Apr 8;19(1):83. doi: 10.1186/s12906-019-2490-z. PMID: 30961586.

Fernandes S, Fond G, Zendjidjian X, Michel P, Baumstarck K, Lancon C, Berna F, Schurhoff F, Aouizerate B, Henry C, Etain B, Samalin L, Leboyer M, Llorca PM, Coldefy M, Auquier P, Boyer L. The Patient-Reported Experience Measure for Improving qUality of care in Mental health (PREMIUM) project in France: study protocol for the development and implementation strategy. Patient Prefer Adherence. 2019 Jan 21;13:165-177. doi: 10.2147/PPA.S172100. eCollection 2019. PMID: 30718945

Misdrahi D, Tessier A, Daubigney A, Meissner WG, Schurhoff F, Boyer L, Godin O, Bulzacka E, Aouizerate B, Andrianarisoa M, Berna F, Capdevielle D, Chereau-Boudet I, D'Amato T, Dubertret C, Dubreucq J, Faget-Agius C, Lançon C, Mallet J, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Llorca PM, Fond G; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort. J Clin Psychiatry. 2019 Jan 8;80(1). pii: 18m12246. doi: 10.4088/JCP.18m12246. PMID: 30695288.

Allé MC, Berna F, Berntsen D. Individuals with psychotic-like experiences exhibit enhanced involuntary autobiographical memories. Psychiatry Res. 2019 Jan 15;273:281-287. doi:10.1016/j.psychres.2019.01.050. PMID: 30677715.

Godin O, Fond G, Bulzacka E, Schürhoff F, Boyer L, Myrtille A, Andrianarisoa M, Aouizerate B, Berna F, Capdevielle D, Chereau I, Dorey JM, Dubertret C, Dubreucq J, Faget C, Lancon C, Leignier S, Mallet J, Misdrahi D, Passerieux C, Rey R, Roux P, Vidailhet P, Costagliola D; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, Leboyer M, Llorca PM. Validation and refinement of the clinical staging model in a French cohort of outpatient with schizophrenia (FACE-SZ). Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jan 10;92:226-234. doi:10.1016/j.pnpbp.2019.01.003. PMID: 30639161.

Ben Malek H, Philippi N, Botzung A, Cretin B, Berna F, Manning L, Blanc F. Memories defining the self in Alzheimer's disease. Memory. 2019 May;27(5):698-704. doi:10.1080/09658211.2018.1554080. PMID: 30526307.

Fond G, Godin O, Schürhoff F, Berna F, Aouizerate B, Capdevielle D, Chereau I, D'Amato T, Dubertret C, Dubreucq J, Faget C, Leignier S, Lançon C, Mallet J, Marulaz L, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Leboyer M; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, Boyer L, Llorca PM. Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort. J Affect Disord. 2019 Feb 15;245:468-474. doi:10.1016/j.jad.2018.11.004. PMID: 30428447.

Schürhoff F, Fond G, Berna F, Bulzacka E, Godin O, Boyer L, Misdrahi D, Andrianarisoa M, Brunel L, Coulon N, Aouizerate B, Capdevielle D, Chereau I, D'Amato T, Dubertret C, Dubreucq J, Faget C, Gabayet F, Mallet J, Rey R, Lancon C, Passerieux C, Schandrin A, Urbach M, Vidailhet P, Leboyer M, Llorca PM; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice. Encephale. 2019 Feb;45(1):9-14. doi: 10.1016/j.encep.2018.07.007. PMID: 30327207.

Schandrin A, Norton J, Raffard S, Aouizerate B, Berna F, Brunel L, Chereau-Boudet I, D'Amato T, Denizot H, Dubertret C, Dubreucq J, Faget C, Fond G, Gabayet F, Llorca PM, Mallet J, Misdrahi D, Passerieux C, Rey R, Schurhoff F, Urbach M, Bonnet S, Capdevielle D; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. A multi-dimensional approach to the relationship between insight and aggressiveness in schizophrenia: Findings from the FACE-SZ cohort. Schizophr Res. 2019 Feb;204:38-45. doi:10.1016/j.schres.2018.07.029. PMID: 30082179.

Roux P, Urbach M, Fonteneau S, Berna F, Brunel L, Capdevielle D, Chereau I, Dubreucq J, Faget-Agius C, Fond G, Leignier S, Perier CC, Richieri R, Schneider P, Schürhoff F, Tronche AM, Yazbek H, Zinetti-Bertschy A; FondaMental Advanced Centers of Expertise in Schizophrenia (FACE-SCZ) Collaborators, Passerieux C, Brunet-Gouet E. Screening for cognitive deficits with the Evaluation of Cognitive Processes involved in Disability in Schizophrenia scale. Clin Rehabil. 2019 Jan;33(1):113-119. doi: 10.1177/0269215518787324. PMID: 30012064.

Weiner L, Flin A, Causin JB, Weibel S, Bertschy G. A case study of suicidality presenting as a restricted interest in Autism Spectrum Disorder. BMC Psychiatry: in press

Weibel S, Lopez R, Micoulaud-Franchi JA, Bioulac S, Lecendreux M, B Bertschy G. Overuse or underuse of methylphenidate in adults in France: commentary on Pauly et al. 2018. British Journal of Clinical Pharmacology: 2019; 85: 273-274

Boulos L-J, Nasseef MT, McNicholas M, Mechling A, Harsan L-A, Darcq E, Ben Hamida S and Kieffer BL (2019) TouchScreen-based phenotyping: altered stimulus/reward association and lower perseveration to gain a reward in mu opioid receptor knockout miceScientific Reports 9(1):4044 PMID:30858487. 

Mann A, Moulédous L, Froment C, O'Neill PR, Dasgupta P, Günther T, Brunori G, Kieffer BL, Toll L, Bruchas MR, Zaveri NT, Schulz S. Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists. Sci Signal. 2019 12(574) PMID:30914485 

Ehrlich AT, Semache M, Gross F, Dafonte D, Runtz L, Colley C, Mezni A, LeGouill C, Lukashova V, Hogue M, Darcq E, Bouvier M and Kieffer BL (2019) Biased signaling of the mu opioid receptor in heterologous cells translates to neurons and reveals the desirable profile of buprenorphineiScience 14:47-57 PMID:30925410. 

Meirsman AC; Ben Hamida S; Clarke E; de Kerchove d’Exaerde A; Darcq E and Kieffer BL (2019) GPR88 in D1R- and D2R-type medium spiny neurons differentially regulates affective and motor behaviorseNeuro PMID 31346000. 

Nasseef MdT, Puneet Singh J, Ehrlich AT, McNicholas M, Park DW, Ma W, Kulkarni P, Kieffer BL and Darcq E (2019) Oxycodone-mediated activation of the mu opioid receptor reduces whole brain functional connectivity in miceACS Pharm Transl Sci 2(4):264-274. PMID:32259060. 

Otsu Y, Darcq E, Pietrajtis K, Matyas F, Schwartz E, Bessaih T, Abi Gerges S, Rousseau CV, Grand T, Dieudonné S, Paoletti P, Acsady L, Agulhon C, Kieffer BL and Diana MA (2019) Control of aversion by glycine-activated GluN1/3A NMDA receptors in the adult Medial HabenulaScience 366, 250-254 PMID 31601771.
 

Ehrlich AT, Kieffer BL, Darcq E (2019) Current strategies toward safer mu opioid receptor drugs for pain management. Expert Opin Ther Targets Feb 25 PMID 30802415.
 

Kieffer BL (2019) An Anti-Opioid System, Courtesy of a Worm Model. New England J Med 381, 2067-2069, PMID 31747732.